Compare Cigna Corp (CI) vs EPAM Systems Inc (EPAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs EPAM Systems Inc — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while EPAM Systems Inc trades at $99.88 (market cap $5.02B). The key difference: Cigna Corp is far larger — about 14.7× EPAM Systems Inc's market cap, and Cigna Corp pays a 2.24% dividend while EPAM Systems Inc pays none. Which is the better fit depends on your goals.
| CI | EPAM | |
|---|---|---|
Market Cap | $73.56B | $5.02B |
Sector | Health | Technology |
52-Week High | $311.00 | $221.40 |
52-Week Low | $244.41 | $76.04 |
Enterprise Value | $98.27B | $4.39B |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
EPAM Systems trades at $97.43, up 4.68% today, but faces bearish technical signals with resistance at $99. The company delivered strong Q2 2026 earnings beats with EPS of $3.38 versus $3.16 expected, though revenue guidance was lowered due to slower North American growth. Valuation metrics appear attractive with P/E of 13.22 and P/S of 0.94, while profitability remains solid with 7.15% net margin.
Despite near-term headwinds, EPAM's partnership with OpenAI and strong AI-native revenue growth provide long-term catalysts. Risks include software services demand softness and competitive pressures. Analyst consensus remains bullish with $117.27 price target (20% upside), though investors should monitor execution against revised guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About EPAM Systems Inc
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →
